Related Experiment Videos
Pain pressure threshold in cluster headache patients
G Bono1, F Antonaci, G Sandrini
1University Centre for Adaptive Disorders and Headache, Pavia, Italy.
Cephalalgia : an International Journal of Headache
|February 1, 1996
Summary
Cluster headache patients exhibit a lower pain perception threshold (PPT) in both head and shoulder areas compared to controls. This reduced sensitivity, particularly on the symptomatic side, suggests a central nervous system mechanism in cluster headache development.
Area of Science:
- Neurology
- Pain Medicine
Background:
- Cluster headache (CH) is a debilitating neurological disorder characterized by severe unilateral head pain.
- Understanding the sensory changes associated with CH is crucial for elucidating its pathogenesis.
Purpose of the Study:
- To investigate pain perception threshold (PPT) differences in cluster headache patients compared to healthy controls.
- To explore variations in PPT between symptomatic and non-symptomatic sides and during different phases of the disease.
Main Methods:
- Pressure algometry was used to assess PPT at multiple cranial points and the deltoid in 58 cluster headache patients and 50 controls.
- Patients were evaluated during cluster periods and remission, with 14 retested.
- Comparisons were made between symptomatic and non-symptomatic sides, and correlations with illness duration were examined.
Main Results:
- Cluster headache patients demonstrated significantly lower PPT in the head and deltoid compared to controls.
- A lower PPT was observed on the symptomatic side in both episodic and chronic CH patients.
- This asymmetry was more pronounced during cluster periods than during remission, with the lowest PPT found in the temporal muscle region.
Conclusions:
- Reduced PPT in cluster headache patients suggests an underlying central mechanism contributing to the condition.
- The findings highlight altered sensory processing in the trigeminovascular system.
- Further research into central sensitization may offer new therapeutic targets for cluster headache.